Press release
Lawsuit filed for Investors who lost money with shares of Illumina, Inc. (NASDAQ: ILMN)

A lawsuit was filed on behalf of investors in Illumina, Inc. (NASDAQ: ILMN) shares over alleged securities laws violations.
Investors who purchased shares of Illumina, Inc. (NASDAQ: ILMN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 09, 2023. NASDAQ: ILMN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 10, 2023, Illumina, Inc. revealed that the SEC was investigating the Company's statements regarding its recent acquisition of GRAIL, Inc. ("GRAIL"), including "conduct and compensation of certain members of Illumina and GRAIL management."
Then, on October 17, 2023, Carl Icahn ("Icahn") filed a complaint against current and former directors of Illumina, Inc, alleging direct and derivative claims of breaches of fiduciary duty. The complaint was filed under seal, but according to Reuters, Icahn "told the 13D Monitor Active-Passive Investor Summit in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer diagnostic test maker Grail."
Shares of Illumina, Inc. (NASDAQ: ILMN) declined from $233.42 per share on April 03, 2023, to as low as $89.00 per share on November 10, 2023.
The plaintiff claims that between May 1, 2023 and October 16, 2023, the Defendants failed to disclose to investors that certain of the Company's insiders had personal financial motives for acquiring GRAIL, that, contrary to Illumina's attempts to discount Icahn's criticism, Icahn had accurately concluded that insiders' interests did not align with the Company's best interests, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Illumina, Inc. (NASDAQ: ILMN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Illumina, Inc. (NASDAQ: ILMN) here
News-ID: 3305450 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors who lost money with shares of Enphase Energy, Inc. ( …
An investor, who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH), filed a lawsuit over alleged violations of Federal Securities Laws by Enphase Energy, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Enphase Energy, Inc. (NASDAQ: ENPH) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2026. NASDAQ: ENPH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Long-Term Investors in shares of Fiserv, Inc. (NYSE: …
An investigation was announced for current long-term investors in shares of Fiserv, Inc. (NYSE: FI) concerning potential breaches of fiduciary duties by certain directors and officers of Fiserv, Inc.
Investors who are current long term investors in Fiserv, Inc. (NYSE: FI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Ardent Health, Inc. (NYSE: ARDT) Investor Alert: Deadline in Lawsuit on March 09 …
A deadline is coming up on March 09, 2026 in the lawsuit filed for certain investors of Ardent Health, Inc. (NYSE: ARDT) over alleged securities laws violations by Ardent Health, Inc.
Investors who purchased shares of Ardent Health, Inc. (NYSE: ARDT) have certain options and there are strict and short deadlines running. Deadline: March 09, 2026. Ardent Health, Inc. (NYSE: ARDT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
Sina Corporation (formerly NASDAQ: SINA) Investor Alert: Investigation of potent …
An investigation on behalf of investors in shares of Sina Corporation (formerly NASDAQ: SINA) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors inSina Corporation (formerly NASDAQ: SINA shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in Sina Corporation (formerly NASDAQ:…
More Releases for Illumina
AI in Biotech Market Is Booming Worldwide | NVIDIA, Illumina
According to HTF Market Intelligence, the Global AI in Biotech market to witness a CAGR of 18.5% during the forecast period (2025-2030). The Latest Released AI in Biotech Market Research assesses the future growth potential of the AI in Biotech market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf
HTF MI just released the Global Microarray Biochips Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Microarray Biochips Market are: Thermo Fisher Scientific,…
Metagenomics Market: Gaining Unprecedented Momentum | Illumina, PerkinElmer
IMR posted new studies guide on Metagenomics Market Insights with self-defined Tables and charts in presentable format. In the Study you may locate new evolving Trends, Drivers, Restraints, Opportunities generated via targeting market related stakeholders. The boom of the Metagenomics marketplace became specifically driven with the aid of the growing R&D spending internationally.
Metagenomics Market Size Was Valued at USD 2.05 Billion in 2023, and is Projected to Reach USD 6.31…
Bioinformatics Market: Know Opportunity Ahead | Illumina, QIAGEN, Wuxi NextCODE
The latest study released on the Global Bioinformatics Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Bioinformatics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Biochips Market Emerging Trends, Size, Share, Growth may Make Driving Growth Vol …
Biochips Market Analysis Report is structured with the meticulous efforts of an innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. This report also offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. Biochips Market analyses the industry based on different factors like growth trends, consumer volume, and market size, demand…
Biochips Market Share 2020-26, Illumina, PerkinElmer, QIAGEN
The latest study on the Global Biochips market report represents a deep appraisal of the international industry. The research report on the worldwide Biochips market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Biochips industry status and authorized projection related to the Biochips market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also offers an in-depth overview…